Atrial Fibrillation Management and Outcomes

Atrial fibrillation is an irregular heart rhythm in which the upper chambers of the heart quiver rather than beat in a coordinated way, allowing blood to pool and form clots that can travel to the brain and cause stroke. Research in this area examines how best to reduce that clot risk through anticoagulant drugs like warfarin and newer agents such as rivaroxaban and dabigatran, as well as whether restoring normal rhythm through catheter ablation offers lasting benefits beyond medications alone. A central challenge is risk stratification — identifying which patients are most likely to suffer serious complications so that treatment intensity can be calibrated accordingly — since both undertreating and overtreating carry real harms. Active investigation continues into refining clinical guidelines, improving ablation techniques, and understanding why some patients do well on rate control alone while others require more aggressive intervention.

Works

149,186

Total citations

2,309,058

Keywords

Atrial FibrillationAnticoagulant TherapyCatheter AblationStroke PreventionRisk StratificationGuidelines